| A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation F Schwarz, W Huang, C Li, BL Schulz, C Lizak, A Palumbo, S Numao, ... Nature chemical biology 6 (4), 264-266, 2010 | 222 | 2010 |
| Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2 C Schliemann, A Palumbo, K Zuberbühler, A Villa, M Kaspar, E Trachsel, ... Blood, The Journal of the American Society of Hematology 113 (10), 2275-2283, 2009 | 178 | 2009 |
| A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels A Palumbo, F Hauler, P Dziunycz, K Schwager, A Soltermann, F Pretto, ... British journal of cancer 104 (7), 1106-1115, 2011 | 94 | 2011 |
| Site-specific and stoichiometric conjugation of cationic porphyrins to antiangiogenic monoclonal antibodies CMA Alonso, A Palumbo, AJ Bullous, F Pretto, D Neri, RW Boyle Bioconjugate chemistry 21 (2), 302-313, 2010 | 59 | 2010 |
| A general method for the selection of high-level scFv and IgG antibody expression by stably transfected mammalian cells K Zuberbühler, A Palumbo, C Bacci, L Giovannoni, R Sommavilla, ... Protein Engineering, Design & Selection 22 (3), 169-174, 2009 | 45 | 2009 |
| F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth G Acker, A Palumbo, D Neri, P Vajkoczy, M Czabanka Journal of neuro-oncology 129, 33-38, 2016 | 16 | 2016 |
| B7-h4 antibodies and methods and use thereof C Kaplan, A Palumbo, K Miller, H Park, N Mendoza, M Ghoddusi US Patent 11,939,383, 2024 | 2 | 2024 |
| Anti-cc chemokine receptor 8 (ccr8) antibodies and methods of use thereof SD Barbee, Y Shujun, M Meury, A Palumbo, T Wong, K Zuberbuhler, ... US Patent App. 18/248,979, 2023 | | 2023 |
| Anticorps b7-h4 et leurs procédés d'utilisation M Ghoddusi, C Kaplan, N Mendoza, K Miller, A Palumbo, H Park | | 2021 |
| B7-h4 antibodies and methods of use thereof C Kaplan, A PALUMBO, K Miller, H Park, N MENDOZA, M GHODDUSI | | 2021 |
| Anticorpos contra b7-h4 e métodos de uso dos mesmos C Kaplan, A Palumbo, K Miller, H Park, N Mendoza, M Ghoddusi | | 2020 |
| B7-h4 antibodies and methods of use thereof C KAPLAN, A PALUMBO, K Miller, H Park, N MENDOZA, M GHODDUSI | | 2019 |
| Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma G Acker, SK Piper, AL Datwyler, T Broggini, I Kremenetskaia, ... Oncotarget 9 (45), 27760, 2018 | | 2018 |
| Second generation direct acting antiviral agents improve clinical resource utilization required for hepatitis C eradication C Mahoney, M Crosby, S Hartz, A Palumbo, M McLean Journal of Hepatology 1 (66), S296, 2017 | | 2017 |
| Supplementary information: A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation F Schwarz, W Huang, C Li, BL Schulz, C Lizak, A Palumbo, S Numao, ... Reading and engineering N-linked protein glycosylation in Escherichia coli, 81, 2010 | | 2010 |
| Antibody-drug conjugates targeting tumour angiogenesis A Palumbo ETH Zurich, 2010 | | 2010 |
| In vivo characterization of vascular targeting strategies using F8-SIP antibody against the ED A of fibronectin G Parmaksiz, M Czabanka, A Palumbo, D Neri, P Vajkoczy EUROPEAN JOURNAL OF MEDICAL RESEARCH 14, 5-6, 2009 | | 2009 |
| In vivo characterization of vascular targeting strategies using F8-SIP antibody against the ED A domain of fibronectin M Czabanka, G Parmaksiz, A Palumbo, D Neri, P Vajkoczy Journal of Vascular Research 46, 24-24, 2009 | | 2009 |
